Xu L - Search Results

1

GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT3.

Chen Z, Xu L, Lin S, Huang H, Long Q, Liu J. Chen Z, et al. Among authors: xu l. Cancer Biol Ther. 2024 Dec 31;25(1):2420383. doi: 10.1080/15384047.2024.2420383. Epub 2024 Nov 2. Cancer Biol Ther. 2024. PMID: 39487760 Free PMC article.

2

A novel mouse model of gastric cancer with human gastric microenvironment.

Zheng MJ, Wang J, Chen YW, Xu L, Xue DD, Fu W, Zhang YF, Du Q, Zhao Y, Ling LJ, Ding Q, Liu XA, Zha XM, Zheng W, Xia TS, Wang S. Zheng MJ, et al. Among authors: xu l. Cancer Lett. 2012 Dec 1;325(1):108-15. doi: 10.1016/j.canlet.2012.06.011. Epub 2012 Jun 28. Cancer Lett. 2012. PMID: 22750094

3

A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer.

Wan X, Shi W, Ma L, Wang L, Zheng R, He J, Wang Y, Li X, Zha X, Wang J, Xu L. Wan X, et al. Among authors: xu l. Clin Transl Med. 2024 May;14(5):e1681. doi: 10.1002/ctm2.1681. Clin Transl Med. 2024. PMID: 38725048 Free PMC article.

4

Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer.

Xu L, Liu J, An Y, Zhou L, Sun H, Xu Z, Wang D, Liang Z, Xu C, Wang B, Li W. Xu L, et al. Among authors: xu c, xu z. BMC Cancer. 2024 Aug 8;24(1):979. doi: 10.1186/s12885-024-12747-z. BMC Cancer. 2024. PMID: 39118022 Free PMC article.

5

FGL1: a novel biomarker and target for non-small cell lung cancer, promoting tumor progression and metastasis through KDM4A/STAT3 transcription mechanism.

Liu TY, Yan JS, Li X, Xu L, Hao JL, Zhao SY, Hu QL, Na FJ, Li HM, Zhao Y, Zhao MF. Liu TY, et al. Among authors: xu l. J Exp Clin Cancer Res. 2024 Aug 1;43(1):213. doi: 10.1186/s13046-024-03140-6. J Exp Clin Cancer Res. 2024. PMID: 39085849 Free PMC article.

6

Biological effect of ribosomal protein L32 on human breast cancer cell behavior.

Xu L, Wang L, Jiang C, Zhu Q, Chen R, Wang J, Wang S. Xu L, et al. Mol Med Rep. 2020 Sep;22(3):2478-2486. doi: 10.3892/mmr.2020.11302. Epub 2020 Jul 6. Mol Med Rep. 2020. PMID: 32705264 Free PMC article.

7

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.

Xu L, Zhang Y, Tian K, Chen X, Zhang R, Mu X, Wu Y, Wang D, Wang S, Liu F, Wang T, Zhang J, Liu S, Zhang Y, Tu C, Liu H. Xu L, et al. J Exp Clin Cancer Res. 2018 Oct 29;37(1):261. doi: 10.1186/s13046-018-0929-6. J Exp Clin Cancer Res. 2018. PMID: 30373602 Free PMC article.

8

Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer.

Zhang J, Li Q, Wu Y, Wang D, Xu L, Zhang Y, Wang S, Wang T, Liu F, Zaky MY, Hou S, Liu S, Zou K, Lei H, Zou L, Zhang Y, Liu H. Zhang J, et al. Among authors: xu l. Cell Commun Signal. 2019 Feb 20;17(1):15. doi: 10.1186/s12964-019-0328-4. Cell Commun Signal. 2019. PMID: 30786890 Free PMC article.

9

Human mammary microenvironment better regulates the biology of human breast cancer in humanized mouse model.

Zheng MJ, Wang J, Xu L, Zha XM, Zhao Y, Ling LJ, Wang S. Zheng MJ, et al. Among authors: xu l. Med Oncol. 2015 Feb;32(2):427. doi: 10.1007/s12032-014-0427-4. Epub 2015 Jan 9. Med Oncol. 2015. PMID: 25572806

10

Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer.

Li H, Zhu L, Xu L, Qin K, Liu C, Yu Y, Su D, Wu K, Sheng Y. Li H, et al. Among authors: xu l. Mol Carcinog. 2017 Jan;56(1):3-17. doi: 10.1002/mc.22338. Epub 2015 Jul 24. Mol Carcinog. 2017. PMID: 26207516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,211 results

Search Page

Filters